8-arylxanthines

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260/242.4

C07D 473/04 (2006.01) C07D 473/06 (2006.01) C07D 473/08 (2006.01)

Patent

CA 1271473

8-ARYLXANTHINES Abstract of the Disclosure 1,3-alkylsubstituted-8-(3,4-,3- or 4-substituted phe- nyl)xanthines and pharmaceutically acceptable salts of such com- pounds are disclosed. The 3-substituents are hydrogen, dimethylaminomethyl, or 2,3-dihydroxypropyloxy. The 4- substituents are selected from hydroxy, cyano, -NHCON(R5)2, -C(=NH)N(R5)2, -NH-C(=NH)N(R5)2, with each R5 independently being hydrogen or an alkyl group of one to three carbons and provided that when the 3-substituent is hydrogen the 4-substituent is not hydroxy or hydrogen. The compounds are potent adenosine receptor antagonists having relatively low lipophilicity. The compounds are intended for use as bronchodilators and cardiotonics.

551660

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

8-arylxanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 8-arylxanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-arylxanthines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1226637

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.